Metabolic Syndrome
Also known as: Insulin Resistance Syndrome · Syndrome X · Cardiometabolic Syndrome
Metabolic syndrome is a cluster of biomarker and anthropometric findings — central adiposity, elevated triglycerides, low HDL, elevated blood pressure, and impaired fasting glucose — that together raise long-term cardiovascular and diabetes risk.
What you need to know
Metabolic syndrome is not a single disease but a constellation of biomarker findings that travel together: central adiposity, triglyceride elevation, low HDL, elevated blood pressure, and impaired fasting glucose. The clinical threshold is three of five criteria. The underlying physiology is insulin resistance combined with chronic low-grade inflammation. oMeds maps metabolic syndrome through the standardized biomarker panel — Lipids, A1C, fasting insulin, hs-CRP, ApoB — and addresses it through metabolic-focused optimization pathways including GLP-1 receptor agonists, lifestyle intervention, and biomarker recalibration.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Diagnostic biomarkers
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.